|
Volumn 37, Issue 4, 2005, Pages 1720-1721
|
Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CYCLOSPORIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ADOLESCENT;
ADULT;
AGED;
CHILD;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
EPSTEIN BARR VIRUS;
FEMALE;
FOLLOW UP;
HEPATITIS;
HUMAN;
LIVER FAILURE;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
MALE;
PARTIAL HEPATECTOMY;
PRIORITY JOURNAL;
SEPSIS;
ADOLESCENT;
ADULT;
CAUSE OF DEATH;
CHILD;
CHILD, PRESCHOOL;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER DISEASES;
LIVER FAILURE, ACUTE;
LIVER TRANSPLANTATION;
MALE;
REOPERATION;
SURVIVAL ANALYSIS;
|
EID: 20344401828
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.03.141 Document Type: Conference Paper |
Times cited : (32)
|
References (3)
|